Prince Pharmaceutical Past Earnings Performance
Past criteria checks 0/6
Prince Pharmaceutical has been growing earnings at an average annual rate of 20.1%, while the Pharmaceuticals industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 6.5% per year.
Key information
20.1%
Earnings growth rate
20.4%
EPS growth rate
| Pharmaceuticals Industry Growth | 18.5% |
| Revenue growth rate | 6.5% |
| Return on equity | -2.0% |
| Net Margin | -2.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Prince Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 737 | -15 | 76 | 56 |
| 31 Mar 24 | 745 | 0 | 74 | 55 |
| 31 Dec 23 | 753 | 15 | 73 | 55 |
| 30 Sep 23 | 723 | 20 | 71 | 53 |
| 30 Jun 23 | 692 | 24 | 70 | 50 |
| 31 Mar 23 | 702 | 38 | 68 | 61 |
| 31 Dec 22 | 713 | 52 | 66 | 72 |
| 30 Sep 22 | 669 | 45 | 60 | 81 |
| 30 Jun 22 | 626 | 39 | 54 | 89 |
| 31 Mar 22 | 534 | 15 | 51 | 84 |
| 31 Dec 21 | 441 | -8 | 47 | 79 |
| 31 Dec 20 | 296 | -34 | 61 | 78 |
| 31 Dec 19 | 250 | 0 | 48 | 29 |
Quality Earnings: 6935 is currently unprofitable.
Growing Profit Margin: 6935 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6935 is unprofitable, but has reduced losses over the past 5 years at a rate of 20.1% per year.
Accelerating Growth: Unable to compare 6935's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6935 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (11.9%).
Return on Equity
High ROE: 6935 has a negative Return on Equity (-2.05%), as it is currently unprofitable.